September 20, 2021 Life Science Tools M&A, Partnerships

Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence

Omniome’s high accuracy short-read sequencing platform expected to significantly expand PacBio’s market opportunity Acquisition expected to accelerate the adoption of SMRT Sequencing, PacBio’s leading long-read sequencing platform PacBio also closes $300 million PIPE financing in support of transaction MENLO PARK, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”),... Read more

September 20, 2021 Lab Top-10 Life Science Tools

Thermo Fisher Scientific Adds Digital PCR to Genetic Analysis Capabilities

Applied Biosystems QuantStudio Absolute Q Digital PCR System*, the first integrated digital PCR solution, is ideal for oncology, cell and gene therapy development and other research applications WALTHAM, Mass., Sept. 20, 2021 /PRNewswire/ — Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, today launched the Applied Biosystems QuantStudio Absolute Q Digital PCR... Read more

September 15, 2021 Acad, Gov/Utilities Chromatography Clinical Research/Diagn. Lab Top-10 Licensing, IP, and Legal Life Science Tools PAI Top-10

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations

FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda’s Targeted Therapy for NSCLC Patients with EGFR Exon20 Insertion Mutations Oncomine Dx Target Test now approved as CDx for five targeted NSCLC therapies in the U.S. CARLSBAD, Calif., Sept. 15, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher... Read more

September 15, 2021 Life Science Tools PR/Corporate

Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle

Sep 15, 2021 Diverse investments from Israel, Mexico, Poland, South Africa, United Kingdom and United States SAN DIEGO, Sept. 15, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) has selected seven new genomics companies to join the third global funding cycle of Illumina Accelerator. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups,... Read more

September 14, 2021 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

09/14/2021 LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced today that it has entered into a definitive agreement to acquire Agena Bioscience,... Read more

September 9, 2021 Life Science Tools M&A, Partnerships Product Launch

Roche signs definitive share purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseases

Roche to acquire the TIB Molbiol Group with the expectation to close in fourth quarter of 2021 TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemic The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use... Read more

September 8, 2021 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bio-Techne and Carterra Initiate a Clinical Research Collaboration for COVID-19 Variant Analysis

SEPTEMBER 08, 2021 Companies bring together cutting-edge technologies and expertise to advance the world’s understanding of COVID-19 variants’ mechanism of action MINNEAPOLIS and SALT LAKE CITY, Sept. 8, 2021 /PRNewswire/ — Bio-Techne, a leading supplier of high-quality and innovative tools for life science research, therapeutic manufacturing and clinical diagnostics and Carterra Inc., the world leader in... Read more

September 7, 2021 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

Sep 7, 2021 SAN DIEGO, Sept. 7, 2021 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) and Merck (known as MSD outside the United States and Canada) today announced a partnership to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency (HRD). Patients whose tumors are HRD-positive may be eligible for... Read more

September 1, 2021 Life Science Tools Product Launch

SCIEX presents industry first multi-capillary system for CE-SDS, the BioPhase 8800 system

Instrument ushers in a new phase of biologic characterization, empowering scientists to analyze more samples and molecules to meet next-gen drug development challenges September 01, 2021 Framingham, MA — SCIEX, a global leader in life science analytical technologies and Danaher operating company, presents the latest capillary electrophoresis solution, the BioPhase 8800 system. This is the only... Read more